{
 "name": "東洋",
 "slug": "tw-4105",
 "aliases": [
  "台灣東洋藥品工業股份有限公司",
  "TTY",
  "4105"
 ],
 "ticker": "4105",
 "industry": "生技醫療業",
 "website": "www.tty.com.tw",
 "summary": "東洋（4105）是上櫃的生技醫療類股公司，1960 年成立，2001 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "台灣東洋藥品工業股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "TTY",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2001-09-27",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "1960-07-22",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "林全",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "侯靜蘭",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 2486499590,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "安侯建業聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "www.tty.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 911422,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；本次回查官方115年09月營收申報，原claim/value/unit/as_of一致並保留；出表日1151017。僅更正source及補此note。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 3.63,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；本次回查官方115年09月營收申報，原claim/value/unit/as_of一致並保留；出表日1151017。僅更正source及補此note。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 7.42,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；本次回查官方115年09月營收申報，原claim/value/unit/as_of一致並保留；出表日1151017。僅更正source及補此note。"
  },
  {
   "claim": "主要產品：Pulmivex（Aumolertinib）",
   "value": "第三代EGFR-TKI肺癌口服標靶藥；東洋六堵廠製造，2026-08-01納入台灣健保",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.tty.com.tw/rwd1181/store/F3/Q3_IR%20Conference_202609Ch.pdf",
   "note": "來源未列完整藥證字號與精確核准日，未據此寫成產品許可。"
  },
  {
   "claim": "主要產品：Lipo-AB",
   "value": "微脂體抗生素；美國持續出貨，澳洲、中東國家陸續領證",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.tty.com.tw/rwd1181/store/F3/Q3_IR%20Conference_202609Ch.pdf",
   "note": "來源未列完整藥證字號與精確核准日，未據此寫成產品許可。"
  },
  {
   "claim": "主要產品：Bobimixyn",
   "value": "自製抗生素新藥，列入2026年營運重點產品",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.tty.com.tw/rwd1181/store/F3/Q3_IR%20Conference_202609Ch.pdf",
   "note": "來源未列完整藥證字號與精確核准日，未據此寫成產品許可。"
  },
  {
   "claim": "主要產品：Cubiyo（TTY_2D）",
   "value": "抗生素產品；公司規劃2026年第4季出貨",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.tty.com.tw/rwd1181/store/F3/Q3_IR%20Conference_202609Ch.pdf",
   "note": "來源未列完整藥證字號與精確核准日，未據此寫成產品許可。"
  },
  {
   "claim": "催化劑：Lipo-AB",
   "value": "六堵廠新增凍乾產線啟動運轉｜2026-Q4（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.tty.com.tw/rwd1181/store/F3/Q3_IR%20Conference_202609Ch.pdf",
   "note": "2026-09-16法說預估；截至2026-10-22未取得後續完成確認，不標已完成。"
  },
  {
   "claim": "催化劑：TTY_2D（Cubiyo）",
   "value": "產品出貨｜2026-Q4（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-09-16",
   "source": "https://www.tty.com.tw/rwd1181/store/F3/Q3_IR%20Conference_202609Ch.pdf",
   "note": "2026-09-16法說預估；截至2026-10-22未取得後續完成確認，不標已完成。"
  }
 ],
 "provided_by": "public_sources",
 "verified_at": "2026-10-22",
 "url": "https://drugnews.com.tw/companies/tw-4105.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}